227 related articles for article (PubMed ID: 23708084)
1. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.
Werner ME; Cummings ND; Sethi M; Wang EC; Sukumar R; Moore DT; Wang AZ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):463-468. PubMed ID: 23708084
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
[TBL] [Abstract][Full Text] [Related]
3. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
Kim DW; Kim SY; Kim HK; Kim SW; Shin SW; Kim JS; Park K; Lee MY; Heo DS
Ann Oncol; 2007 Dec; 18(12):2009-14. PubMed ID: 17785767
[TBL] [Abstract][Full Text] [Related]
4. An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).
Lee SW; Kim YM; Cho CH; Kim YT; Kim SM; Hur SY; Kim JH; Kim BG; Kim SC; Ryu HS; Kang SB
Cancer Res Treat; 2018 Jan; 50(1):195-203. PubMed ID: 28324920
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.
Wang Y; Liu H; Diao L; Potter A; Zhang J; Qiao Y; Wang J; Proia DA; Tailor R; Komaki R; Lin SH
Clin Cancer Res; 2016 Dec; 22(23):5876-5886. PubMed ID: 27354472
[TBL] [Abstract][Full Text] [Related]
6. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.
Kim TY; Kim DW; Chung JY; Shin SG; Kim SC; Heo DS; Kim NK; Bang YJ
Clin Cancer Res; 2004 Jun; 10(11):3708-16. PubMed ID: 15173077
[TBL] [Abstract][Full Text] [Related]
8. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
9. 2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model.
Peng L; Schorzman AN; Ma P; Madden AJ; Zamboni WC; Benhabbour SR; Mumper RJ
Int J Nanomedicine; 2014; 9():3601-10. PubMed ID: 25114529
[TBL] [Abstract][Full Text] [Related]
10. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
Werner ME; Copp JA; Karve S; Cummings ND; Sukumar R; Li C; Napier ME; Chen RC; Cox AD; Wang AZ
ACS Nano; 2011 Nov; 5(11):8990-8. PubMed ID: 22011071
[TBL] [Abstract][Full Text] [Related]
11. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J
Breast Cancer Res Treat; 2008 Mar; 108(2):241-50. PubMed ID: 17476588
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer.
Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728
[TBL] [Abstract][Full Text] [Related]
13. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.
Safran H; King T; Choy H; Gollerkeri A; Kwakwa H; Lopez F; Cole B; Myers J; Tarpey J; Rosmarin A
Cancer; 1996 Sep; 78(6):1203-10. PubMed ID: 8826941
[TBL] [Abstract][Full Text] [Related]
15. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
Lau DH; Ryu JK; Gandara DR; Morgan R; Doroshow J; Wilder R; Leigh B
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
17. An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer.
Park IH; Sohn JH; Kim SB; Lee KS; Chung JS; Lee SH; Kim TY; Jung KH; Cho EK; Kim YS; Song HS; Seo JH; Ryoo HM; Lee SA; Yoon SY; Kim CS; Kim YT; Kim SY; Jin MR; Ro J
Cancer Res Treat; 2017 Jul; 49(3):569-577. PubMed ID: 27618821
[TBL] [Abstract][Full Text] [Related]
18. Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer.
Ma X; Lee C; Zhang T; Cai J; Wang H; Jiang F; Wu Z; Xie J; Jiang G; Li Z
J Nanobiotechnology; 2021 Sep; 19(1):284. PubMed ID: 34551763
[TBL] [Abstract][Full Text] [Related]
19. Single-agent paclitaxel and radiation for non-small cell lung cancer.
Akerley W; Choy H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):85-9. PubMed ID: 10210545
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous radiochemotherapy with paclitaxel in non-small cell lung cancer: a clinical phase I study.
Vogt HG; Kolotas C; Martin T; Schneider LV; Neeb A; Mitrou PS; Diergarten K; Dornoff W; Zamboglou N
Semin Oncol; 1996 Dec; 23(6 Suppl 15):26-30. PubMed ID: 8996594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
